This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van der Kraaij, A. M. Articles by Koster, J. F. Search for Related Content PubMed PubMed Citation Articles by van der Kraaij, A. M. Articles by Koster, J. F.

Circulation, Vol 80, 158-164, Copyright © 1989 by American Heart Association

ARTICLES

Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)- cyanidanol-3

AM van der Kraaij, HG van Eijk and JF Koster
Department of Biochemistry, Erasmus University Rotterdam, The Netherlands.

In this study, we investigated the role of oxygen-derived free radicals and iron in mediating myocardial injury during ischemia and reperfusion. Iron is of special interest because it may enhance tissue injury during ischemia and reperfusion by catalyzing the formation of highly reactive hydroxyl radicals (by modified Haber-Weiss or Fenton reactions). Rat hearts, perfused by the Langendorff method, were subjected to global ischemia (15 minutes at 37 degrees C) and reperfusion. The effects of two iron chelators, 1,2-dimethyl-3-hydroxy- 4-pyridone (L1) and 5-hydroxy-2-hydroxymethyl-4-pyrone (kojic acid), and one antioxidant, (+)-cyanidanol-3, on contractile function, coronary flow, lactate dehydrogenase release, and lactate production were studied. The combination of these iron chelators is of special importance because L1 is known to prevent lipid peroxidation, induced by ADP/Fe3+ and NADPH in microsomes, in contrast to kojic acid. We found significant protection of contractile function (apex displacement) during reperfusion with 50 microM L1 and 20 microM (+)- cyanidanol-3 (p less than 0.01, n = 6), whereas no protection was found with 50 microM kojic acid (n = 6). Measurements of lactate dehydrogenase release during reperfusion showed a protective pattern similar to that found for heart contractile function, although 50 microM kojic acid also showed a significantly lower lactate dehydrogenase release during the first 10 minutes of reperfusion. No differences in coronary resistance or lactate release were found between the various groups. Our findings indicate that iron and oxygen- derived free radicals are important in the pathogenesis of postischemic reperfusion injury probably because of the formation of hydroxyl radicals.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K.M. Mitchell, A.L. Dotson, K.M. Cool, A. Chakrabarty, S.H. Benedict, and S.M. LeVine Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis Multiple Sclerosis, November 1, 2007; 13(9): 1118 - 1126. [Abstract] [PDF]

				R. Marshall, F. Tricta, R. Galanello, G. Leoni, D. Kirkland, S. Minto, and M. Spino Chromosomal aberration frequencies in patients with thalassaemia major undergoing therapy with deferiprone and deferoxamine in a comparative crossover study Mutagenesis, September 1, 2003; 18(5): 457 - 463. [Abstract] [Full Text] [PDF]

				B. Meyns, R. Autschbach, A. Boning, W. Konertz, K. Matschke, F. Schondube, K. Wiebe, and E. Fischer Coronary artery bypass grafting supported with intracardiac microaxial pumps versus normothermic cardiopulmonary bypass: a prospective randomized trial Eur. J. Cardiothorac. Surg., July 1, 2002; 22(1): 112 - 117. [Abstract] [Full Text] [PDF]

				B. Meyns, P. Sergeant, T. Nishida, B. Perek, M. Zietkiewicz, and W. Flameng Micropumps to support the heart during CABG Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 169 - 174. [Abstract] [Full Text] [PDF]

				M. S. Sweeney The Hemopump in 1997: a clinical, political, and marketing evolution Ann. Thorac. Surg., August 1, 1999; 68(2): 761 - 763. [Abstract] [Full Text] [PDF]

				T.-S. Lee, M.-S. Shiao, C.-C. Pan, and L.-Y. Chau Iron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice Circulation, March 9, 1999; 99(9): 1222 - 1229. [Abstract] [Full Text] [PDF]

				L. Cragg, R. P. Hebbel, W. Miller, A. Solovey, S. Selby, and H. Enright The Iron Chelator L1 Potentiates Oxidative DNA Damage in Iron-Loaded Liver Cells Blood, July 15, 1998; 92(2): 632 - 638. [Abstract] [Full Text] [PDF]

				B Meyns, S Ozaki, P Sergeant, Y Nishimura, and W Flameng Circulatory support during minimally invasive coronary surgery Perfusion, July 1, 1998; 13(4): 265 - 271. [PDF]

				B. P. Meyns, P. T. Sergeant, W. J. Daenen, and W. J. Flameng Left Ventricular Assistance With the Transthoracic 24F Hemopump for Recovery of the Failing Heart Ann. Thorac. Surg., August 1, 1995; 60(2): 392 - 397. [Abstract] [Full Text]